DGX vs GEVO · P/E 22, rev $5.94B vs rev $89.4M
Quest Diagnostics Incorporated (DGX) versus Gevo Inc (GEVO) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Gevo Inc (GEVO) is a specialty chemicals company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported GEVO revenue for 2026-06-30 was $89.4M. Net income was -$198.6M. GEVO currently screens at market cap $378.5M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. GEVO currently screens at market cap $378.5M.
Not investment advice. Open the DGX and GEVO stock pages for the full models.
Not investment advice.